Imidin Für Kinder, (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a topical alpha‑adrenergic agonist. It binds to alpha‑1 and alpha‑2 receptors on the blood vessels of the nasal mucosa, causing vasoconstriction. This reduces blood flow, decreases mucosal edema, and opens the airway, providing rapid decongestion.

The specific dose and frequency are determined by the prescribing clinician based on the child’s age, weight, and severity of symptoms. Typically, a few sprays per nostril are used, but the exact regimen should always follow the healthcare professional’s instructions.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and only under the guidance of a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imidin Für Kinder uses Xylometazoline, an imidazoline class decongestant, which typically provides rapid relief with a lower incidence of rebound congestion compared with phenylephrine. Compared with oxymetazoline, it has a similar efficacy profile but may be preferred in some pediatric formulations due to formulation differences.

Store the nasal spray at room temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme heat. Keep the bottle tightly closed when not in use to maintain sterility and potency.

The spray is applied directly into each nostril while the child is seated upright. Typically, one or two sprays per nostril are administered, but the exact number should follow the prescribing clinician’s directions. Avoid blowing the nose immediately after use to allow the medication to act.

Serious adverse events, although rare, include severe hypertension, cardiac arrhythmias, anaphylactic reactions, nasal ulceration, and persistent nosebleeds. If any of these occur, discontinue use immediately and seek medical attention.

Children with known hypersensitivity to Xylometazoline or any component of the formulation should avoid the product. It is also contraindicated in patients with uncontrolled hypertension, severe cardiovascular disease, or recent nasal surgery unless directed by a physician.